Workers at Shasun Pharma’s active pharmaceutical ingredient (API) and formulation facility at Pondicherry struck work on Saturday.

In a stock exchange filing on Monday, the company said it is doing the needful to resume operations at the earliest. It has termed the strike "illegal".

Established in 1986, the Puducherry API facility is dedicated to the manufacture of Ibuprofen (anti-inflammatory and pain drug) for supply to world markets. The formulation facility, spread over 9,290 sq m, was commissioned in 2005. It has an annual production capacity of over 3.0 billion tablets and 120 million capsules.

The company's share closed 0.78 per cent lower at Rs 63.90 on Monday on the BSE.

(This article was published on June 17, 2013)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.